Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns medical and healthcare-related publications and documentation, specifically regarding the updated participation criteria for researchers looking for eligible subjects in clinical research studies.
    Difference
    53%
    Check dated 2024-05-22T07:40:26.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    15 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely represents an update or adjustment in the estimated completion date for the medical study related to antitumor activity and pharmacokinetics of zolbetuximab in participants with gastric and gastroesophageal junction adenocarcinoma.
    Difference
    0.0%
    Check dated 2024-05-11T17:25:11.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '03 27 Suspended 03 26 03 27 03' to '05 09 Recruiting 05 08 (Estimated) 05 09 04'. This change indicates a shift from a suspended status to a recruiting status, possibly related to medical and healthcare-related publications and documentation.
    Difference
    0.5%
    Check dated 2024-05-10T08:18:44.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:36:25.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.